Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026)
Neuronetics (STIM) reported Depreciation & Amortization (CF) of $745000.0 for Q1 2026, down 18.22% year-over-year from $911000.0 in Q1 2025, and down 2.87% quarter-over-quarter from $767000.0 in Q4 2025.
Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $745000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $745000.0, down 18.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (up 36.1% YoY), and the FY2025 annual result was $3.5 million, up 67.15% from the prior year.
- Depreciation & Amortization (CF) fell to $745000.0 in Q1 2026 per STIM's latest filing, from $767000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $911000.0 in Q1 2025 and troughed at $319000.0 in Q1 2022.
- A 5-year average of $584529.4 and a median of $516000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) soared 106.85% in 2022, then fell 18.22% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $604000.0 in 2022, then dropped by 16.72% to $503000.0 in 2023, then retreated by 11.33% to $446000.0 in 2024, then soared by 71.97% to $767000.0 in 2025, then decreased by 2.87% to $745000.0 in 2026.
- Business Quant data shows STIM's Depreciation & Amortization (CF) at $745000.0 in Q1 2026, $767000.0 in Q4 2025, and $886000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | 745,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 745,000.00 |
| Mar 31, 2026 | 745,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Dec 31, 2023 | 503,000.00 |
| Dec 31, 2023 | 503,000.00 |